Dresden biologists make living sperm glow

January 15, 2020

How do female insects manage to keep the sperm fresh for months after mating? This is a central question of the sperm biologists of the Chair of Applied Zoology headed by Prof. Dr. Klaus Reinhardt. Now the scientists presented their first promising results in the journal Scientific Reports.

Dr. Cornelia Wetzker borrowed an innovative label-free technique from cancer research in order to investigate the metabolism of living biological tissues. This involves the measurement of the decay of the intrinsic fluorescence of the metabolic coenzyme NADH - a matter of nanoseconds, requiring a specialised microscope. This measure, also known as fluorescence lifetime, serves as a cell-specific signature and characterises the specific metabolic pathways of the tissue. Cancer cells have a shorter NADH fluorescence lifetime, are thus more glycolytic and can therefore be distinguished from healthy cells.

With this method, Dr. Cornelia Wetzker has now succeeded in examining the metabolism of intact tissues of the fruit fly outside the body. She analysed the metabolism of sperm in the storage organs of male and female animals as well as other tissues of the insect. The sperm were investigated in still intact closed organs, which in the male serve for storage before and in the females after mating. The team thus found that the sperm had a highly glycolytic metabolism similar to that of cancer cells. Other cells, such as intestinal, gland and fat cells, were in a much more oxidative state.

Using this method, the biologists found a first clue to their initial question of how the sperm remain fresh in the body of the insect females. They discovered that the fluorescence lifetime of another autofluorescent metabolic coenzyme called FAD differs between the sperm in the male and in the female body.

With regard to the clinical application of this technique, fluorescence lifetime imaging microscopy (FLIM) is proving to be highly promising. "The fluorescence lifetime signature analysis could even be automated with the help of neural networks", suspects Dr. Cornelia Wetzker. "And since the method is not dangerous, there is no reason why it should not be used on living humans or animals," adds Professor Klaus Reinhardt.
-end-


Technische Universität Dresden

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.